IRIS
MAZZUCCHELLI, Roberta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.307
EU - Europa 5.993
AS - Asia 5.925
SA - Sud America 1.426
AF - Africa 285
Continente sconosciuto - Info sul continente non disponibili 21
OC - Oceania 15
AN - Antartide 1
Totale 25.973
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.029
SG - Singapore 1.828
VN - Vietnam 1.169
BR - Brasile 1.131
RU - Federazione Russa 1.059
UA - Ucraina 1.018
CN - Cina 852
IT - Italia 709
DE - Germania 611
HK - Hong Kong 586
IE - Irlanda 569
TR - Turchia 554
SE - Svezia 521
DK - Danimarca 387
FR - Francia 376
FI - Finlandia 310
KR - Corea 223
GB - Regno Unito 222
IN - India 152
CA - Canada 144
AR - Argentina 98
MX - Messico 97
BD - Bangladesh 89
CI - Costa d'Avorio 89
IQ - Iraq 73
ID - Indonesia 63
ZA - Sudafrica 58
EC - Ecuador 57
JP - Giappone 56
MA - Marocco 41
PK - Pakistan 39
CO - Colombia 38
BE - Belgio 31
NL - Olanda 31
PL - Polonia 31
SA - Arabia Saudita 27
VE - Venezuela 27
ES - Italia 26
UZ - Uzbekistan 25
IR - Iran 24
EG - Egitto 22
PH - Filippine 21
CL - Cile 20
MY - Malesia 20
PE - Perù 20
RO - Romania 20
PY - Paraguay 18
EU - Europa 17
JO - Giordania 17
TH - Thailandia 16
AT - Austria 14
DZ - Algeria 14
KE - Kenya 14
TW - Taiwan 14
KZ - Kazakistan 11
TN - Tunisia 11
AE - Emirati Arabi Uniti 10
AU - Australia 9
UY - Uruguay 9
CR - Costa Rica 8
ET - Etiopia 8
AL - Albania 7
AZ - Azerbaigian 7
CH - Svizzera 7
GR - Grecia 7
LB - Libano 7
OM - Oman 7
BH - Bahrain 6
HU - Ungheria 6
KG - Kirghizistan 6
NP - Nepal 6
NZ - Nuova Zelanda 6
PT - Portogallo 6
BO - Bolivia 5
HN - Honduras 5
NG - Nigeria 5
PA - Panama 5
AO - Angola 4
CZ - Repubblica Ceca 4
LT - Lituania 4
RS - Serbia 4
SN - Senegal 4
XK - ???statistics.table.value.countryCode.XK??? 4
AM - Armenia 3
JM - Giamaica 3
PS - Palestinian Territory 3
SV - El Salvador 3
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BG - Bulgaria 2
CG - Congo 2
DO - Repubblica Dominicana 2
EE - Estonia 2
GD - Grenada 2
GT - Guatemala 2
GY - Guiana 2
MM - Myanmar 2
MU - Mauritius 2
SC - Seychelles 2
SY - Repubblica araba siriana 2
Totale 25.943
Salva come PNG Salva come JPEG
Città #
Ashburn 1.851
Singapore 1.187
Jacksonville 1.028
Chandler 976
Fairfield 758
Dallas 699
Des Moines 580
Boardman 568
Dublin 568
Hong Kong 558
San Jose 453
Wilmington 401
Ho Chi Minh City 389
New York 382
Woodbridge 330
Houston 282
Seattle 275
Hanoi 252
The Dalles 234
Lawrence 224
Princeton 224
Beijing 215
San Mateo 215
Lauterbourg 210
Cambridge 207
Ann Arbor 192
Moscow 154
Centro 135
Hefei 134
Los Angeles 132
São Paulo 97
San Diego 92
Abidjan 89
Munich 87
Milan 86
Helsinki 73
Buffalo 72
Haiphong 65
Chicago 64
Da Nang 60
London 51
Council Bluffs 49
Vancouver 48
Tokyo 44
Redmond 42
Santa Clara 42
Turku 39
Mexico City 36
Shanghai 36
Frankfurt am Main 35
Baghdad 34
Orem 34
Rio de Janeiro 34
Washington 32
Brussels 31
Guangzhou 31
Miano 30
Wuhan 30
Pune 28
Warsaw 28
Belo Horizonte 27
Chennai 27
Ancona 26
Rome 25
Marche 24
Biên Hòa 23
Montreal 23
Denver 22
Tashkent 22
Brooklyn 21
Izmir 21
Turin 21
Atlanta 20
Manchester 20
Columbus 19
Hải Dương 19
Phoenix 19
Curitiba 18
Erbil 18
Guayaquil 18
San Francisco 18
Durban 17
Istanbul 17
Porto 17
Quito 17
Salvador 17
Johannesburg 16
Stockholm 16
Amman 15
Brasília 14
Campinas 14
Norwalk 14
Porto Alegre 14
Salt Lake City 14
Toronto 14
Elk Grove Village 13
Jiaxing 13
Amsterdam 12
Brasov 12
Fortaleza 12
Totale 16.061
Salva come PNG Salva come JPEG
Nome #
Cellular Modulators of the NRF2/KEAP1 Signaling Pathway in Prostate Cancer 421
Metabolic phenotype of bladder cancer 260
Morphometric index of adult renal cell carcinoma. Comparison with the Fuhrman grading system. 217
The trophoblast cell surface antigen 2 and miR-125b axis in urothelial bladder cancer 202
AT-rich interactive domain 1A protein expression in normal and pathological pregnancies complicated by preeclampsia 196
Predicting future cancer burden in the United States by artificial neural networks 190
Clinical progression of megacalycosis in a girl with a solitary kidney: The lesson learned 185
Androgen Receptor Signaling Pathway in Prostate Cancer: From Genetics to Clinical Applications 184
A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer. 181
Ciliary neurotrophic factor (CNTF) and its receptor (CNTFRα) signal through MAPK/ERK pathway in human prostate tissues: a morphological and biomolecular study 176
"Pathological" reflection on European urology: extended, saturation, and systematic prostate biopsies. 174
Secondary neoplasms of the urinary system and male genital organs. 167
Chromosomal Abnormalities in Macroscopically Normal Urothelium in Patiens with Bladder pT1 and pT2a Urothelial Carcinoma: a Fluorescence in situ hybridisation Study and Correlation with Histologic Features. 166
Germline and somatic mutations in prostate cancer: Focus on defective DNA repair, PARP inhibitors and immunotherapy 161
HER2 expression and gene amplification in pT2a Gleason score 6 prostate cancer incidentally detected in cystoprostatectomies: comparison with clinically detected andreogen-dependent and androgen-independent cancer. 157
[Interstitial cystitis: minimal diagnostic criteria]. 156
2004 World Health Organization Classification of the Noninvasive Urothelial Neoplasms: Inherent Problems and Clinical Reflections 156
Tumor VEGF expression correlates with tumor stage and identifies prognostically different groups in clear cell renal cell carcinoma patients 156
Nuclear changes in the normal-looking columnar epithelium adjacent to and distant from prostatic intraepithelial neoplasia and prostate cancer. Morphometric analysis in whole-mount sections. 154
alpha-methylacyl-CoA racemase (P504S)/34 beta E12/p63 triple cocktail stain in prostatic adenocarcinoma after hormonal therapy 153
Atypical foci, suspicious but not diagnostic of malignancy in prostate needle biopsies (also referred to as "atypical small acinar proliferation suspicious for but not diagnostic of malignancy") 153
Morphologic Variants of Epithelial and Neuroendocrine Tumors of the Prostate. The Pathologist's Point of View 152
A randomized phase IIb presurgical study of finasteride vs. low-dose flutamide vs. placebo in men with prostate cancer. Efficacy monitored by karyometry 152
Active surveillance for low-risk prostate cancer. 151
Metabolic Alterations in Renal and Prostate Cancer 151
[Thin glomerular basement membrane disease]. 148
ANCA-Associated Glomerulonephritis and Anti-Phospholipid Syndrome in a Patient with SARS-CoV-2 Infection: Just a Coincidence? 147
Immunohistochemical expression of somatostatin receptor subtypes in prostate tissue from cystoprostatectomies with incidental prostate cancer. 145
Basal cell hyperplasia and basal cell carcinoma of the prostate: a comprehensive review and discussion of a case with c-erbB-2 expression. 145
Adipose cannabinoid CB1 receptor expression and adiponectin correlate with microvascular damage in human kidney 145
Analytical and Qualitative Cytology and Histology. Reflection on the past two years. 144
Effect of complete androgen blockade on pathologic stage and resection margin status of prostate cancer: Progress pathology report of the Italian PROSIT study 143
Added Clinical Value of Whole-mount Histopathology of Radical Prostatectomy Specimens: A Collaborative Review 143
Angiogenesis as prognostic factor in small renal tumors 142
Low HtrA1 expression in patients with long‑standing ulcerative colitis and colorectal cancer 141
Improving inter-observer agreement and certainty level in diagnosing and grading papillary urothelial neoplasms: usefulness of a Bayesian belief network. 140
2005 update on pathology of prostate biopsies with cancer 140
Autophagic Gene Polymorphisms in Liquid Biopsies and Outcome of Patients with Metastatic Clear Cell Renal Cell Carcinoma 140
Adult primary paratesticular mesenchymal tumors with emphasis on a case presentation and discussion of spermatic cord leiomyosarcoma. 139
Genitourinary cancers: molecular determinants for personalized therapies 139
AT-rich interactive domain 1A (ARID1A) cannot be considered a morphological marker for prostate cancer progression: A pilot study 139
Narrative review of prostate cancer grading systems: Will the Gleason scores be replaced by the grade groups? 138
Contemporary grading of prostate cancer: 2017 update for pathologists and clinicians 137
Identification of BRAF V600E mutation in odontogenic tumors by high-performance MALDI-TOF analysis 137
A contemporary update on pathology reporting for urinary bladder cancer. 136
[Nephrotic proteinuria with type 2 diabetes mellitus and autoimmune thyroiditis]. 133
A painful diagnosis 133
Androgen ablation therapy for prostate carcinoma suppresses the immunoreactive telomerase subunit hTERT 132
Urothelial papillary lesions. Development of a Bayesian Belief Network for diagnosis and grading 132
Morphological diagnosis of urothelial neoplasms. 131
Epigenetic modifications and modulators in prostate cancer 131
Ciliary Neurotrophic Factor Modulates Multiple Downstream Signaling Pathways in Prostate Cancer Inhibiting Cell Invasiveness 131
Expression of pi-class glutathione S-transferase: two populations of high grade prostatic intraepithelial neoplasia with different relations to carcinoma 130
Combining radiotherapy with immunocheckpoint inhibitors or CAR-T in Renal Cell Carcinoma 130
Variants and Variations in Epithelial Renal Cell Tumors in Adults: The Pathologist's Point of View 130
PUNLMP or not PUNLMP? This is the problem. 128
Classification and grading of the non-invasive urothelial neoplasms: recent advances and controversies. 128
Upregulation of Tissue and Urinary Nicotinamide N-Methyltransferase in Bladder Cancer: Potential for the Development of a Urine-Based Diagnostic Test. 128
HtrA1 in human urothelial bladder cancer: a secreted protein and a potential novel biomarker. 128
Strong immunohistochemical expression of fibroblast growth factor receptor 3, superficial staining pattern of cytokeratin 20, and low proliferative activity define those papillary urothelial neoplasms of low malignant potential that do not recur. 128
Adipose cannabinoid CBI receptor and adiponectin expression correlate with microvascular damage in human-kidney 127
pT1 high-grade bladder cancer: histologic criteria, pitfalls in the assessment of invasion, and substaging 127
Pseudocarcinomatous hyperplasia associated with primary lymphoma in the urinary bladder: a case report 127
Increased VEGF165 expression in HCT116 colon cancer cells after transient transfection with a GFP vector encoding HIF-1 gene. 125
Prognostic role of Furhman grade and vascular endothelia growth factor in pT1a clear cell carcinoma in partial nephrectomy specimens 124
Morphological assessment of radical prostatectomy specimens. A protocol with clinical relevance. 124
Biphasic Tumors of the Urogenital Tract: Selected Topics 124
Changes in the normal-looking epithelium in prostates with PIN or cancer. 121
Prostate cancer with cribriform morphology: diagnosis, aggressiveness, molecular pathology and possible relationships with intraductal carcinoma 120
alpha-Methylacyl coenzyme A racemase, Ki-67, and topoisomerase IIalpha in cystoprostatectomies with incidental prostate cancer 119
Pathology and molecular updates in tumors of the prostate: towards a personalized approach. 119
Re: Karim A. Touijer, James A. Eastham. The Sentinel Lymph Node Concept and Novel Approaches in Detecting Lymph Node Metastasis in Prostate Cancer. Eur Urol 2016;70:738–9: Sentinel Lymph Nodes in Adipose Tissue Surrounding the Prostate Gland and Seminal Vesicles as Observed in Virtual Whole-mount Histologic Slides 119
Immunohistochemical detection and localization of somatostatin receptor subtypes in prostate tissue from patients with bladder outlet obstruction. 118
Joint appraisal of the radical prostatectomy specimen by the urologist and the uropathologist: together, we can do it better 117
Changes produced in the urothelium by traditional and newer therapeutic procedures for bladder cancer. 117
A magnetic resonance imaging-based nomogram for predicting clinically significant prostate cancer at radical prostatectomy 116
Renal sarcoma associated with adult polycystic kidney disease. A case report and literature review. 116
Expression of basic fibroblast growth factor, its receptors and syndecans in bladder cancer. 116
Gleason grading of prostate carcinoma in needle biopsies vs. radical prostatectomy specimens. 115
Immunohistochemical expression of Endothelin-1 and Endothelin-A and Endothelin-B receptors in high-grade prostatic intraepithelial neoplasia and prostate cancer. 115
Urothelial changes induced by therapeutic procedures for bladder cancer. A review. 113
Morphological classification and definition of benign, preneoplastic and non-invasive neoplastic lesions of the urinary bladder. 113
Prostate carcinoma I: prognostic factors in radical prostatectomy specimens and pelvic lymph nodes 113
Recurrent papillary urothelial neoplasm of low malignant potential. Subtle architectural disorder detected by quantitative analysis in DAXX-immunostained tissue sections. 113
Elevation of c-FLIP in castrate-resistant prostate cancer antagonizes therapeutic response to androgen receptor-targeted therapy. 113
Pathology of prostate cancer and focal therapy ('male lumpectomy'). 112
KIDNEY CANCER: NOT A SINGLE DISEASE. 112
Molecular techniques and prostate cancer diagnostic. 112
Case diagnosis as positive identification in prostatic neoplasia 112
Extent of cancer of less than 50% in any prostate needle biopsy core: how many millimeters are there? 112
Update on histopathological evaluation of lymphadenectomy specimens from prostate cancer patients 111
Prostate cancer in 2021: Novelties in prognostic and therapeutic biomarker evaluation 111
Dose-dependent effects of curcumin on 22Rv1 prostate cancer cell line 110
Specimen orientation by marking the peripheral end: (potential) clinical advantages in prostate biopsy. 109
Long Non-coding RNAs in prostate cancer with emphasis on second chromosome locus associated with prostate-1 expression 109
Somatostatin receptor subtypes in hormone-refractory (castration-resistant) prostatic carcinoma. 109
Urothelial and incidental prostate carcinoma in prostates from cystoprostatectomies for bladder cancer: is there a relationship between urothelial and prostate cancer? 108
Pathological definition and difficulties in assessing positive margins in radical prostatectomy specimens. 108
Molecular mechanisms in prostate cancer. A review. 108
Evaluation of prognostic factors in radical prostatectomy specimens with cancer 108
Totale 13.974
Salva come PNG Salva come JPEG
Categoria #
all - tutte 117.231
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 117.231
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021115 0 0 0 0 0 0 0 0 0 0 0 115
2021/20221.661 117 392 55 93 11 109 47 108 106 132 107 384
2022/20233.227 282 248 202 277 224 840 8 202 738 17 125 64
2023/20241.857 312 56 90 268 317 427 26 41 13 44 31 232
2024/20253.689 389 311 190 89 116 109 350 176 925 257 352 425
2025/20269.477 530 704 752 1.023 855 663 1.824 955 805 790 207 369
Totale 26.234